ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Oxycodone versus sufentanil on pain management for spinal PVP surgery.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAnesthesia option is critical for Percutaneous vertebroplasty (PVP) procedure in terms of its analgesic effect, sedation, adverse reactions and patient satisfaction. Oxycodone and sufentanil are commonly used as analgesic agents for surgeries in clinic. The comparison of clinical effect between oxycodone and sufentanil for pain management in PVP has not been elucidated. QUESTIONS/PURPOSES: In this retrospective study, we investigated the clinical effect of oxycodone injection for pain management in spinal percutaneous vertebroplasty (PVP) surgery in terms of the analgesic effect, sedation, adverse reactions and patient satisfaction.
methodsA total of 100 patients who had previously undergone spinal PVP surgery were selected for a retrospective study from December 2022 to June 2024 including the oxycodone group (50 cases) and the sufentanil group (50 cases). The sufentanil group received 1 mg/kg propofol + 0.15ug/kg sufentanil as anesthetic, while the oxycodone group received 0.1 mg/kg oxycodone + 1 mg/kg propofol. The analgesic effects and safety of both groups were compared.
resultsThe intraoperative additional dose of propofol, MOAA/S score, and number of body movements of the oxycodone group were lower than the sufentanil group (p < 0.05); on postoperative day 1, the changes in SBP, DBP, HR, and SpO2 in the oxycodone group were lower than the sufentanil group (p < 0.05); 1 day and 3days after surgery, the oxycodone group had significantly lower VAS scores (p < 0.001); The oxycodone group showed significantly lower postoperative pain intensity compared with the sufentanil group. On postoperative day 1, mean VAS scores were 2.76 ± 0.82 in the oxycodone group and 4.30 ± 0.73 in the sufentanil group (P < 0.05). On postoperative day 3, VAS scores were 1.26 ± 0.44 vs. 2.04 ± 0.70, respectively (P < 0.05).
conclusionUsing oxycodone hydrochloride for intraoperative pain management in patients undergoing percutaneous vertebroplasty can effectively alleviate pain, maintain hemodynamic stability, improve intraoperative and postoperative analgesic effects, and has good safety, making it worth promoting.
Indexed as
Identifiers
41324678What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.